News

FDA OKs pertuzumab injection as combination therapy for metastatic breast cancer - 2916.jpg

A study finds chemotherapy-free treatment shows promise for some patients with metastatic breast cancer

21 August 2026
A negative regulator of p53, MDM4, is a therapeutic target in cutaneous melanoma - 3252.png

Math and medicine join forces to solve a cancer mystery

21 August 2026
default thumbnail

About Us

20 August 2026
A negative regulator of p53, MDM4, is a therapeutic target in cutaneous melanoma - 3252.png

Phase 3 INTerpath-001 trial of intismeran autogene plus pembrolizumab met endpoints of RFS and DMFS in patients with completely resected stage IIB-IV melanoma

20 August 2026
colorectal 16 9

Colorectal cancer may quietly damage nerves prior to chemotherapy

20 August 2026
generic lab research study cropped

New chip mimics how cancer spreads

20 August 2026
gut bacteria petri dish microbiome

Bacteria found in lung tumours may boost immune response to cancer

20 August 2026
An unprecedented view of the immune system’s killer cells - Credit @ F. Lemaitre @ UNIGE

Supercentenarians have an abundance of cancer-killing immune cells

20 August 2026
DNA 16 9

Study identifies previously missed DNA mutation pattern in colorectal cancer

20 August 2026
cancer patient generic

Researchers create unified framework to explain one of cancer’s major drivers

20 August 2026
Children Generic

Hidden drivers of aggressive childhood cancer revealed

20 August 2026
A microscopy image depicting immune receptor distribution analysis in human T cells - Credit: University of Southampton

βIII-tubulin in malignant tumours: unveiling its biological functions, mechanisms and roles in drug resistance

20 August 2026
Back to Top